Feedback / Questions
zaltenibart (OMS906) - Omeros
5-methoxy-2-aminoindane (CMND-100) - Clearmind Medicine
https://www.businesswire.com/news/home/20250321322641/en/Omeros-Corporation-Provides-Update-of-Ongoing-Zaltenibart-Phase-3-PNH-Clinical-Trial-Program
Mar 21, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next